Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2031
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Osteoarthritis Market Overview
The osteoarthritis market size was valued at $2.5 billion in 2021 and is expected to achieve a CAGR of more than 4% during 2021-2031. OA is a slowly progressive joint disease characterized by degradation of the articular (hyaline) cartilage that coats the bone proximities of synovial joints. Contrary to the previous notion that OA is exclusively a disorder of articular cartilage, studies have demonstrated it is a disease of the whole joint, adversely affecting the subchondral bone, tendons, ligaments, and synovium. Damage to these structures causes irritation and pain, which intensifies with disease progression and can significantly decrease individuals’ quality of life.
To gain more information on the osteoarthritis market forecast, download a free report sample
The osteoarthritis market research report provides an overview of the risk factors, comorbidities, and global and historical trends for hand OA, knee OA, and hip OA in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It also includes a 10-year epidemiological forecast for total prevalent cases and diagnosed prevalent cases of hand OA, knee OA, and hip OA segmented by age (18 years and older) and sex in these markets.
Market Size (2021) | $2.5 billion |
CAGR (2021 – 2031) | >4% |
Key Segments | Hand OA, Knee OA, and Hip OA |
Key Age Segments (Hand OA) | 18-19 Years, 20-29 Years, 30-39 Years, 40-49 Years, 50-59 Years, 60-69 Years, 70-79 Years, and Above 80 years |
Key Sex Segments (Hand OA) | Men and Women |
Leading Players | Pfizer, Janssen, GlaxoSmithKline, Bayer, Novartis, Eli Lilly, Merck, Pacira BioSciences, Kolon TissueGene, Biosplice Therapeutics, Organogenesis Holdings, Techfields Pharma, and Centrexion Therapeutics |
Osteoarthritis Market Drivers
The major drivers of growth in the osteoarthritis market include the launch of new biologic therapies priced at a substantial premium. The launch of drugs with novel mechanisms of action (MOAs) and disease-modifying effects will shift the treatment regimen towards using patented new drugs, which will also increase the OA market value. Moreover, recent improvements in imaging techniques will facilitate the development of disease-modifying osteoarthritis drugs (DMOADs) and encourage early intervention.
Osteoarthritis Market by Key Segments
The osteoarthritis market can be further segmented into hand OA, knee OA, and hip OA.
For more insights into the segments, download a free report sample
Hand OA Market Segmentation by Age
The hand OA market can be segmented based on age into 18-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.
In 2021, for the 7MM combined, the highest number of diagnosed prevalent cases (symptomatic) was in the age group 60–69 years.
Hand OA Market Analysis by Age
For more age segment insights into the hand OA market, download a free report sample
Hand OA Market Segmentation by Sex
The hand OA market can be segmented based on sex into men and women. In the 7MM combined, the number of diagnosed prevalent cases of osteoarthritis was higher in women than in men in 2021. The differences in the numbers of diagnosed prevalent cases (symptomatic) of hand OA across the sexes and markets may be mostly attributed to differences in the underlying demographic differences in each market, as well as the significant differences in sex-specific diagnosed prevalence.
Hand OA Market Analysis by Sex
For more sex segment insights into the hand OA market, download a free report sample
Hand OA Market Competitive Landscape
Some of the leading players in the osteoarthritis market are Pfizer, Janssen, GlaxoSmithKline, Bayer, Novartis, Eli Lilly, Merck, Pacira BioSciences, Kolon TissueGene, Biosplice Therapeutics, Organogenesis Holdings, Techfields Pharma, and Centrexion Therapeutics.
Reasons to Buy
The report will enable you to:
- Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines.
- Develop business strategies by understanding the trends shaping and driving the global OA therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global OA market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global OA therapeutics market from 2021-2031.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Janssen
GlaxoSmithKline
Bayer
Novartis
Eli Lilly
Merck
Pacira BioSciences
Kolon TissueGene
Biosplice Therapeutics
Organogenesis Holdings
Techfields Pharma
Centrexion Therapeutics
Regeneron
Xalud Therapeutics
Bone Therapeutics
Table of Contents
Table
Figures
Frequently asked questions
-
What was the osteoarthritis market size in 2021?
The osteoarthritis market size was valued at $2.5 billion in 2021.
-
What is the osteoarthritis market growth rate?
The osteoarthritis market is expected to achieve a CAGR of more than 4% during 2021-2031.
-
What are the key segments in the osteoarthritis market?
The key segments in the osteoarthritis market are hand OA, knee OA, and hip OA.
-
What are the key age segments in the hand OA market?
The key age segments in the hand OA market are 18-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.
-
What are the key sex segments in the hand OA market?
The hand OA market can be segmented based on sex into men and women.
-
Who are the leading players in the osteoarthritis market?
Some of the leading players in the osteoarthritis market are Pfizer, Janssen, GlaxoSmithKline, Bayer, Novartis, Eli Lilly, Merck, Pacira BioSciences, Kolon TissueGene, Biosplice Therapeutics, Organogenesis Holdings, Techfields Pharma, and Centrexion Therapeutics.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.